Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BlueJays9293on Mar 02, 2024 8:01pm
138 Views
Post# 35911599

RE:RE:RE:RE:RE:Baxter ramping up hiring for Vantive

RE:RE:RE:RE:RE:Baxter ramping up hiring for VantiveGood conversation MM and G-unit, so in the interest of not causing any confusion I'm going to do the old fashioned, laborious cut/paste, quotation marks format, etc.  Ughhh.

"However, as others and I have said, they may want to create some more excitement around their IPO and nothing creates excitement more than promoting new streams of ( high margin) revenue. Especially ones that could exceed $1-$2B annually in time."  MM

An IPO is technically a launch, and the only question in my mind is if Baxter wants to launch her little old toy rocket by itself, or does she want to strap on some high octane booster rockets called PMX/EAA? 

Baxter knows that all of Vantive's products are just legacy devices and machine/dinosaur's with a flat growth rate in a market that is growing.  If you're flat, in a market that is growing, that means you are shrinking, and that's a fact.  Take away PMX/EAA from that Vantive future slide, and it's beyond dismal.  Oh and PMX/EAA comes with booster rockets too from a PR front,

"Baxter's PMX/EAA makes first major advancement in the treating of Sepsis since Alexander Fleming first discovered Penicillin."  NYT
 
chuckle.

Clearly I say this in jest, but PMX turns a stodgy old Non-innovator Dinosaur, into this like hip stylish walking around town kind of dinosaur.  Instant make over and growth potential all achieved with just one stone.





<< Previous
Bullboard Posts
Next >>